Literature DB >> 11171818

Correlation of oesophageal acid exposure with Barrett's oesophagus length.

R Fass1, R W Hell, H S Garewal, P Martinez, G Pulliam, C Wendel, R E Sampliner.   

Abstract

BACKGROUND: Gastro-oesophageal reflux disease (GORD) plays a major role in the development of Barrett's oesophagus. However, it has yet to be elucidated what factors determine the length of Barrett's mucosa in each individual patient. AIMS: To determine if there is a correlation between oesophageal acid exposure and the length of Barrett's mucosa. We also compared the extent of oesophageal acid exposure between patients with short segment (SSBE) and long segment (LSBE) Barrett's oesophagus.
METHODS: Twenty seven patients with Barrett's oesophagus were recruited prospectively into the study from the outpatient gastroenterology clinic at the Southern Arizona VA Health Care System. Diagnosis of Barrett's oesophagus and its anatomical characteristics were determined during upper endoscopy. Ambulatory 24 hour oesophageal pH monitoring assessed the extent of oesophageal acid exposure.
RESULTS: There was a significant correlation between per cent total time pH less than 4 and length of Barrett's mucosa (r=0.6234, p=0.0005). In addition, there was a significant correlation between per cent upright and supine time pH less than 4 and length of Barrett's mucosa (r=0.5847, p=0.0014 and r=0.6265 p=0.0006, respectively). Patients with SSBE had significantly less oesophageal acid exposure than patients with LSBE, in terms of both per cent total time and per cent supine time pH less than 4 (p<0.05).
CONCLUSIONS: The length of Barrett's mucosa correlated with the duration of oesophageal acid exposure. Patients with LSBE experienced significantly more oesophageal acid exposure than patients with SSBE. Duration of oesophageal acid exposure appears to be an important contributing factor in determining the length of Barrett's mucosa.

Entities:  

Mesh:

Year:  2001        PMID: 11171818      PMCID: PMC1760147          DOI: 10.1136/gut.48.3.310

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori.

Authors:  L Laine; D Lewin; W Naritoku; R Estrada; H Cohen
Journal:  Gastrointest Endosc       Date:  1996-11       Impact factor: 9.427

2.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology.

Authors:  R E Sampliner
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

3.  Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus.

Authors:  T Loughney; C L Maydonovitch; R K Wong
Journal:  Am J Gastroenterol       Date:  1998-06       Impact factor: 10.864

4.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

5.  Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease.

Authors:  M F Vaezi; J E Richter
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

Review 6.  Surgical management of Barrett's esophagus.

Authors:  G W Clark; T R DeMeester
Journal:  Ann Chir Gynaecol       Date:  1995

7.  The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.

Authors:  G M Eisen; R S Sandler; S Murray; M Gottfried
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

8.  Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.

Authors:  R E Sampliner
Journal:  Am J Gastroenterol       Date:  1994-10       Impact factor: 10.864

9.  Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus.

Authors:  B T Cooper; C S Neumann; M A Cox; T H Iqbal
Journal:  Aliment Pharmacol Ther       Date:  1998-09       Impact factor: 8.171

10.  Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus.

Authors:  G Champion; J E Richter; M F Vaezi; S Singh; R Alexander
Journal:  Gastroenterology       Date:  1994-09       Impact factor: 22.682

View more
  32 in total

1.  Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus.

Authors:  Anne L Krarup; Søren S Olesen; Peter Funch-Jensen; Hans Gregersen; Asbjørn M Drewes
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Hiatal hernia, Barrett's esophagus, and long-term symptom control after laparoscopic fundoplication for gastroesophageal reflux.

Authors:  Johannes Miholic; Joumanah Hafez; Johannes Lenglinger; Fritz Wrba; Christiane Wischin; Katrin Schütz; Marcus Hudec
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

3.  Laparoscopic treatment of Barrett's esophagus: long-term results.

Authors:  L Biertho; B Dallemagne; J-M Dewandre; C Jehaes; S Markiewicz; B Monami; C Wahlen; J Weerts
Journal:  Surg Endosc       Date:  2006-11-16       Impact factor: 4.584

Review 4.  Barrett's esophagus--Who, how, how often and what to do with dysplasia?

Authors:  Lawrence C Hookey
Journal:  Can J Gastroenterol       Date:  2006-07       Impact factor: 3.522

Review 5.  Gastro-oesophageal reflux disease.

Authors:  Mark Fox; Ian Forgacs
Journal:  BMJ       Date:  2006-01-14

Review 6.  The relationship between gastroesophageal reflux disease and sleep.

Authors:  Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2009-06

Review 7.  [Correct diagnosis for indication in gastroesophageal reflux disease].

Authors:  A H Hölscher; E Bollschweiler; Ch Gutschow; P Malfertheiner
Journal:  Chirurg       Date:  2005-04       Impact factor: 0.955

Review 8.  Advancements in the analysis of esophageal pH monitoring in GERD.

Authors:  Tiberiu Hershcovici; Anita Gasiorowska; Ronnie Fass
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

Review 9.  Barrett's esophagus in 2016: From pathophysiology to treatment.

Authors:  Irene Martinucci; Nicola de Bortoli; Salvatore Russo; Lorenzo Bertani; Manuele Furnari; Anna Mokrowiecka; Ewa Malecka-Panas; Vincenzo Savarino; Edoardo Savarino; Santino Marchi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

10.  Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.

Authors:  M Solaymani-Dodaran; R F A Logan; J West; T Card; C Coupland
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.